Ursprung des Netzwerks ersten Grades von George Ji
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Sirnaomics, Inc.
 Sirnaomics, Inc. Pharmaceuticals: MajorHealth Technology Sirnaomics, Inc. develops novel targeted therapeutics for critical human diseases. It discovers and develops RNAi therapeutics. The firm pursues its proprietary technologies using pluripotent siRNA cocktail design and nanoparticle-enhanced therapeutic delivery to treat critical human diseases. The company was founded by Patrick Y. Lu, George Ji and David M. Evans in 2007 and is headquartered in Gaithersburg, MD.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Guangzhou Natai Biomedical Technology Co., Ltd.
 Guangzhou Natai Biomedical Technology Co., Ltd. BiotechnologyHealth Technology Part of Sirnaomics, Inc., Guangzhou Natai Biomedical Technology Co., Ltd. is a company that manufactures biomedical products. The company is based in Guangzhou, China. Guangzhou Natai Biomedical Technology Co. was acquired by Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. The Chinese company was founded in 2012 by Yang Lu, Jian Jun Ji, Sheng Gao Tang. Sheng Gao Tang has been the CEO since 2012.
2
| Subsidiary | Biotechnology | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von George Ji
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
 Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sirnaomics, Inc., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. is a Chinese company that develops nucleic acid drugs. The company is based in Suzhou, China. The company was founded in 2008 by Yang Lu, David Mark Evans. Yang Lu has been the CEO since 2008. | Pharmaceuticals: Major | Chief Executive Officer Founder | |
| SIRNAOMICS LTD. | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
Intradigm Corp.
 Intradigm Corp. Pharmaceuticals: MajorHealth Technology Intradigm Corp. develops drugs and therapies. Its RNAi therapeutic platform comprised of proprietary delivery technologies, potent siRNA sequences and innovative siRNA structural features. The company was founded by Puthupparampil Scaria, Martin C. Woodle, Wei-Wu He and Patrick Y. Lu in 2000 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Founder | |
| Sun Yat-Sen University | College/University | Doctorate Degree | |
Emerald BioStructures, Inc.
 Emerald BioStructures, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beryllium LLC, Emerald BioStructures, Inc. is a company that offers products and services in protein X-ray crystallography, specializing in the area of protein crystallization. The company is based in Bainbridge Island, WA. The company was founded by Lance K. Stewart. Emerald BioStructures was acquired by MediChem Research, Inc. on May 31, 2000. | Miscellaneous Commercial Services | Chief Operating Officer | |
Dharmacon, Inc.
 Dharmacon, Inc. Miscellaneous Commercial ServicesCommercial Services Dharmacon, Inc. engages in the research and development for ribonucleic acid synthesis. Its products are gene editing, RNA interference, cDNAs and ORFs, transfection, and viral packaging. The company was founded by Stephen Scaringe in 1995 and is headquartered in Lafayette, CO. | Miscellaneous Commercial Services | Director/Board Member | |
| Imperial College Business School | College/University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| China | 3 |
| Hong Kong | 2 |
| Vereinigtes Königreich | 2 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 3 |
Operativ
| Founder | 8 |
| Chief Executive Officer | 4 |
| President | 3 |
| Chairman | 3 |
| Chief Tech/Sci/R&D Officer | 3 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Patrick Lu | 6 |
| David Evans | 6 |
| Marc Lemaitre | 1 |
| Danny Tang | 1 |
